Cervical Carcinoma Recruiting Phase 2 Trials for Pembrolizumab (DB09037)

Also known as: Carcinoma of the cervix / Carcinoma of cervix

IndicationStatusPhase
DBCOND0029674 (Cervical Carcinoma)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03108495Study of LN-145, Autologous Tumor Infiltrating Lymphocytes in the Treatment of Patients With Cervical CarcinomaTreatment
NCT02628067Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)Treatment
NCT04483544Pembrolizumab and Olaparib in Cervical Cancer PatientsTreatment